What does this research mean for the field?

GPR120 expression is significantly increased in early pregnancy of patients who develop preeclampsia. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To determine the role of GPR120 as a biomarker for predicting and diagnosing preeclampsia in the first trimester.

March 1, 2026Open Access

View Full Paper

The GPR120 as a novel predictive and diagnostic marker for preeclampsia in the first trimester.

Key Points

To determine the role of GPR120 as a biomarker for predicting and diagnosing preeclampsia in the first trimester.
Analyzed GPR120 expression in early pregnancy of patients with preeclampsia.
Developed a nomogram for predicting preeclampsia risk.
Suggested larger multicenter cohorts for validating findings.
GPR120 expression was significantly higher in early pregnancy for preeclampsia patients.
The nomogram demonstrated predictive capabilities for the development of preeclampsia.

Abstract

GPR120 expression is significantly increased in early pregnancy of PE patients. The nomogram exhibited predictive capability for PE development but needs larger, multicenter cohorts for validation.

Demander à l'IA

Bookmark

View Full Paper

Demander à l'IA

Bookmark

View Full Paper

The GPR120 as a novel predictive and diagnostic marker for preeclampsia in the first trimester.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider